纳米技术驱动的生物材料用于慢性肝脏疾病:先进的治疗术的特定阶段策略
Yishui Cai1, Tianqi Nie2, Xi Luo1
1Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), No.1 Du Xue Road, Nansha, Guangzhou 511400, China.
Acta biomaterialia
|January 25, 2026
概括
纳米技术为慢性肝病 (CLD) 提供先进的生物材料,改善向药物输送和早期诊断. 本综述详细介绍了精准医学的特定阶段设计,从脂肪肝到肝硬化.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 肝病学 肝病学是一种肝病学.
背景情况:
- 慢性肝病 (CLDs) 构成一个重大的全球健康挑战,在传统治疗中有效性和毒性问题有限.
- 目前针对非酒精性脂肪性肝病 (NAFLD) 和乙型肝炎的治疗策略,在药物输送和早期检测方面面临障碍.
研究的目的:
- 系统地审查纳米技术驱动的生物材料平台用于CLD,与疾病进展保持一致.
- 详细介绍工程纳米材料如何提高治疗效率和诊断灵敏度,用于各种CLD阶段.
- 提供一个特定阶段的路线图,用于设计下一代CLD精密医学解决方案.
主要方法:
- 系统的回顾纳米技术的进展,通过疾病进展 (NAFLD,NASH,乙型肝炎,纤维化,肝硬化).
- 对工程生物材料平台的分析,重点是肝脏积累,控制释放和治疗效果 (代谢,抗病毒,抗纤维).
- 探索纳米技术增强的诊断工具,包括成像剂和纳米传感器用于早期检测和分期.
主要成果:
- 工程纳米平台显示了增强的肝脏积累和受控的药物释放,改善治疗结果.
- 基于纳米技术的诊断提供了前所未有的灵敏度,用于早期检测和精确的CLD阶段.
- 该审查为生物材料提供了一个特定阶段的设计范式,解决了生物可用性和诊断方面的临床瓶.
结论:
- 纳米技术驱动的生物材料为CLD中精确的解学策略提供了开创性的解决方案.
- 一个特定阶段的设计方法对于开发有效的,个性化的治疗和诊断对于CLD连续性的发展至关重要.
- 本次审查旨在加快创新生物材料的临床转化,以改善CLD管理.
相关概念视频
01:26Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
01:22Chronic Obstructive Pulmonary Disease
2.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
01:25Chronic Kidney Disease I: Introduction
620
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
620
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
607
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
607